Human SLC7A11/CCBR1/xCT ORF/cDNA clone-Adenovirus particle (NM_014331.4)

Cat. No.: vGMAD000772

Pre-made Human SLC7A11/CCBR1/xCT Adenovirus for SLC7A11 overexpression in-vitro and in-vivo. The SLC7A11 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified SLC7A11-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.

At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.

Target products collection

Go to SLC7A11/xCT/SLC7A11/CCBR1 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name Adenovirus Grade Adenovirus quantity
vGMAD000772 Human SLC7A11 Adenovirus particle Research Grade-In vitro 1E+10PFU (1E+10pfu/ml×1ml)
5E+10PFU (1E+10pfu/ml×5ml)
1E+11PFU (1E+10pfu/ml×10ml)
Research Grade-In vivo 1E+11PFU (1E+11pfu/ml×1ml)
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAD000772
Gene Name SLC7A11
Accession Number NM_014331.4
Gene ID 23657
Species Human
Product Type Adenovirus particle (overexpression)
Insert Length 1506 bp
Gene Alias CCBR1,xCT
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Kanamycin
ORF Nucleotide Sequence ATGGTCAGAAAGCCTGTTGTGTCCACCATCTCCAAAGGAGGTTACCTGCAGGGAAATGTTAACGGGAGGCTGCCTTCCCTGGGCAACAAGGAGCCACCTGGGCAGGAGAAAGTGCAGCTGAAGAGGAAAGTCACTTTACTGAGGGGAGTCTCCATTATCATTGGCACCATCATTGGAGCAGGAATCTTCATCTCTCCTAAGGGCGTGCTCCAGAACACGGGCAGCGTGGGCATGTCTCTGACCATCTGGACGGTGTGTGGGGTCCTGTCACTATTTGGAGCTTTGTCTTATGCTGAATTGGGAACAACTATAAAGAAATCTGGAGGTCATTACACATATATTTTGGAAGTCTTTGGTCCATTACCAGCTTTTGTACGAGTCTGGGTGGAACTCCTCATAATACGCCCTGCAGCTACTGCTGTGATATCCCTGGCATTTGGACGCTACATTCTGGAACCATTTTTTATTCAATGTGAAATCCCTGAACTTGCGATCAAGCTCATTACAGCTGTGGGCATAACTGTAGTGATGGTCCTAAATAGCATGAGTGTCAGCTGGAGCGCCCGGATCCAGATTTTCTTAACCTTTTGCAAGCTCACAGCAATTCTGATAATTATAGTCCCTGGAGTTATGCAGCTAATTAAAGGTCAAACGCAGAACTTTAAAGACGCCTTTTCAGGAAGAGATTCAAGTATTACGCGGTTGCCACTGGCTTTTTATTATGGAATGTATGCATATGCTGGCTGGTTTTACCTCAACTTTGTTACTGAAGAAGTAGAAAACCCTGAAAAAACCATTCCCCTTGCAATATGTATATCCATGGCCATTGTCACCATTGGCTATGTGCTGACAAATGTGGCCTACTTTACGACCATTAATGCTGAGGAGCTGCTGCTTTCAAATGCAGTGGCAGTGACCTTTTCTGAGCGGCTACTGGGAAATTTCTCATTAGCAGTTCCGATCTTTGTTGCCCTCTCCTGCTTTGGCTCCATGAACGGTGGTGTGTTTGCTGTCTCCAGGTTATTCTATGTTGCGTCTCGAGAGGGTCACCTTCCAGAAATCCTCTCCATGATTCATGTCCGCAAGCACACTCCTCTACCAGCTGTTATTGTTTTGCACCCTTTGACAATGATAATGCTCTTCTCTGGAGACCTCGACAGTCTTTTGAATTTCCTCAGTTTTGCCAGGTGGCTTTTTATTGGGCTGGCAGTTGCTGGGCTGATTTATCTTCGATACAAATGCCCAGATATGCATCGTCCTTTCAAGGTGCCACTGTTCATCCCAGCTTTGTTTTCCTTCACATGCCTCTTCATGGTTGCCCTTTCCCTCTATTCGGACCCATTTAGTACAGGGATTGGCTTCGTCATCACTCTGACTGGAGTCCCTGCGTATTATCTCTTTATTATATGGGACAAGAAACCCAGGTGGTTTAGAATAATGTCGGAGAAAATAACCAGAACATTACAAATAATACTGGAAGTTGTACCAGAAGAAGATAAGTTATGA
ORF Protein Sequence MVRKPVVSTISKGGYLQGNVNGRLPSLGNKEPPGQEKVQLKRKVTLLRGVSIIIGTIIGAGIFISPKGVLQNTGSVGMSLTIWTVCGVLSLFGALSYAELGTTIKKSGGHYTYILEVFGPLPAFVRVWVELLIIRPAATAVISLAFGRYILEPFFIQCEIPELAIKLITAVGITVVMVLNSMSVSWSARIQIFLTFCKLTAILIIIVPGVMQLIKGQTQNFKDAFSGRDSSITRLPLAFYYGMYAYAGWFYLNFVTEEVENPEKTIPLAICISMAIVTIGYVLTNVAYFTTINAEELLLSNAVAVTFSERLLGNFSLAVPIFVALSCFGSMNGGVFAVSRLFYVASREGHLPEILSMIHVRKHTPLPAVIVLHPLTMIMLFSGDLDSLLNFLSFARWLFIGLAVAGLIYLRYKCPDMHRPFKVPLFIPALFSFTCLFMVALSLYSDPFSTGIGFVITLTGVPAYYLFIIWDKKPRWFRIMSEKITRTLQIILEVVPEEDKL

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T11615-Ab Anti-XCT/ SLC7A11/ CCBR1 monoclonal antibody
    Target Antigen GM-Tg-g-T11615-Ag SLC7A11 VLP (virus-like particle)
    ORF Viral Vector pGMLP002698 Human SLC7A11 Lentivirus plasmid
    ORF Viral Vector pGMLV000645 Human SLC7A11 Lentivirus plasmid
    ORF Viral Vector pGMLV002270 Human SLC7A11 Lentivirus plasmid
    ORF Viral Vector pGMLV002421 Human SLC7A11 Lentivirus plasmid
    ORF Viral Vector pGMAD000772 Human SLC7A11 Adenovirus plasmid
    ORF Viral Vector pGMPC000851 Human SLC7A11 Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector pGMPC000895 Human SLC7A11 Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector pGMPC000954 Human SLC7A11 Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector vGMLP002698 Human SLC7A11 Lentivirus particle
    ORF Viral Vector vGMLV000645 Human SLC7A11 Lentivirus particle
    ORF Viral Vector vGMLV002270 Human SLC7A11 Lentivirus particle
    ORF Viral Vector vGMLV002421 Human SLC7A11 Lentivirus particle
    ORF Viral Vector vGMAD000772 Human SLC7A11 Adenovirus particle


    Target information

    Target ID GM-T11615
    Target Name SLC7A11/xCT
    Gene Group Identifier
    （Target Gene ID in Homo species)         		23657
    Gene ID 100063433 (Equus caballus), 101099374 (Felis catus), 23657 (Homo sapiens), 26570 (Mus musculus)
    310392 (Rattus norvegicus), 483821 (Canis lupus familiaris), 524078 (Bos taurus), 696516 (Macaca mulatta)
    Gene Symbols & Synonyms SLC7A11,Slc7a11,xCT,CCBR1,sut,9930009M05Rik
    Target Alternative Names SLC7A11, xCT,Cystine/glutamate transporter,Amino acid transport system xc-, Calcium channel blocker resistance protein CCBR1, Solute carrier family 7 member 11, xCT,xCT,CCBR1
    Uniprot Accession Q9UPY5,Q9WTR6
    Additional SwissProt Accessions: Q9UPY5,Q9WTR6
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category
    Disease
    Disease from KEGG Ferroptosis
    Gene Ensembl ENSECAG00000022696, ENSG00000151012, ENSMUSG00000027737, ENSCAFG00845022942, ENSBTAG00000034075, ENSMMUG00000020317
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.